NCT03369652 is a NA clinical trial of Medication review in Older Patients, sponsored by Odense University Hospital.

Who is sponsoring NCT03369652?

NCT03369652 is sponsored by Odense University Hospital.

What drugs are being tested in NCT03369652?

Interventions in NCT03369652: Medication review.

What condition does NCT03369652 study?

NCT03369652 studies Older Patients, Medication Review, Cross-sectional Communication.

Is NCT03369652 still recruiting?

NCT03369652 is currently completed. Last updated 19 March 2019.

Last reviewed 2019-03-19 · How we verify

NCT03369652

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telephone Contact Between Hospital and General Practitioner About Medication Review for Older Patients

Completed NA Last updated 19 March 2019

What this trial tests

NA trial testing Medication review in Older Patients in 232 participants. Completed in 30 November 2018.

Timeline

24 November 2017

Primary endpoint
1 November 2018

30 November 2018

Quick facts

Lead sponsor	Odense University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	232
Start date	24 November 2017
Primary completion	1 November 2018
Estimated completion	30 November 2018
Sites	2 locations across Denmark

Drugs / interventions tested

Medication review

Conditions studied

Older Patients — all drugs for Older Patients →
Medication Review — all drugs for Medication Review →
Cross-sectional Communication — all drugs for Cross-sectional Communication →

Sponsor

Odense University Hospital

Who can join

65 and older, any sex, with Older Patients or Medication Review. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this trial, the feasibility of cooperation between clinical pharmacists and physicians by conducting a telephone follow-up conversation between the hospital geriatrician, the general practitioner and the clinical pharmacist is evaluated. During hospital stay the clinical pharmacist and the geriatrician will review older patients' medication and discuss the future treatment with the general practitioner after discharge by telephone or medico-technology. The first part of the feasibility study will be a qualitative baseline measure of characteristics of the participants and work flow. The second part will be a pilot randomized controlled study where participants will be allocated to either usual care or medication review and follow up contact

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Medication review in hospitalised patients to reduce morbidity and mortality.
Bülow C, Clausen SS, Lundh A, Christensen M. · · 2023 · cited 37× · PMID 36688482 · DOI 10.1002/14651858.cd008986.pub4

Verify or expand the search:

Other trials of Medication review

Trials testing the same drug.

NCT07283055 — A Swiss Interprofessional Network for Reviewing Inappropriate Medication in Primary Care · NA · enrolling by invitation
NCT05928104 — Optimising Pharmacist-led Medication Reviews in Primary Care · completed
NCT05756478 — Appropriate Prescribing for Older Adults With Multimorbidity (Pro-M) · NA · completed
NCT05297461 — Impact of Medication Review by Community Pharmacists · NA · completed
NCT04573491 — Implementation of Pharmacogenetic Testing in Hospital Wards · NA · completed

Other recruiting trials for Older Patients

Currently open trials in the same condition.

NCT06906523 — Blood Flow Restriction in Older Adults · NA · active not recruiting
NCT05907694 — Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure · NA · recruiting
NCT06044623 — Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast · Phase 3 · recruiting
NCT05765370 — LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD) · NA · recruiting
NCT05150249 — Prospective Observational Study Based on a Cohort of Geriatric Patients With Hip Fracture Treated in the Centers Belongi · recruiting

Other Odense University Hospital trials

Trials by the same sponsor.

NCT07163091 — Bracing After Ankle Fracture · NA · not yet recruiting
NCT07521696 — Physical Recovery During Bracing After Ankle Fracture (Re-BAF) · NA · not yet recruiting
NCT07466212 — QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy · not yet recruiting
NCT07191379 — Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma · Phase 4 · not yet recruiting
NCT07170085 — Positioning of Children With Acute Respiratory Insufficiency · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03369652 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Odense University Hospital
Last refreshed: 19 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03369652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing